Patents by Inventor Joseph Howing Chan

Joseph Howing Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzophenones as inhibitors of reverse transcriptase
    Patent number: 7273863
    Abstract: The present invention includes benzophenone compounds (I) which are useful in the treatment of HIV infections.
    Type: Grant
    Filed: August 31, 2000
    Date of Patent: September 25, 2007
    Assignee: SmithKline Beecham Corporation
    Inventors: Clarence Webster Andrews, III, Joseph Howing Chan, George Andrew Freeman, Karen Rene Romines, Jeffrey H. Tidwell, Pascal Maurice Charles Pianetti
  • Benzophenones as inhibitors of reverse transcriptase
    Patent number: 6995283
    Abstract: The present invention is directed to beazophenone compounds useful in the inhibition of HIV reverse transcriptase, particularly its resistant varieties.
    Type: Grant
    Filed: February 28, 2002
    Date of Patent: February 7, 2006
    Assignee: SmithKline Beecham Corporation
    Inventor: Joseph Howing Chan
  • Benzophenones as inhibitors of reverse transcriptase
    Publication number: 20040122064
    Abstract: The present invention is directed to benzophenone compounds useful in the inhibition of HIV reverse transcriptase, particularly its resistant varieties.
    Type: Application
    Filed: February 5, 2004
    Publication date: June 24, 2004
    Inventor: Joseph Howing Chan
  • Formamide compounds as therapeutic agents
    Patent number: 6329400
    Abstract: A family of compounds having the general structural formula where W is a reverse hydroxamic acid group, and R1, R2, R3, R4, R5 and R6 are as described in the specification, or a pharmaceutically acceptable salt, solvate, biohydrolyzable ester, biohydrolyzable amide, affinity reagent, or prodrug thereof.
    Type: Grant
    Filed: August 25, 1999
    Date of Patent: December 11, 2001
    Assignee: Glaxo Wellcome Inc.
    Inventors: Robert Carl Andrews, Marc Werner Andersen, Dulce Garrido Bubacz, Joseph Howing Chan, David John Cowan, Michael David Gaul, Daryl Lynn McDougald, David Lee Musso, Michael Howard Rabinowitz, Jennifer Badiang Stanford, Robert William Wiethe
  • Formamide compounds as therapeutic agents
    Patent number: 6191150
    Abstract: A family of compounds having the general structural formula where W is a reverse hydroxamic acid group, and R1, R2, R3, R4, R5 and R6 are as described in the specification, or a pharmaceutically acceptable salt, solvate, biohydrolyzable ester, biohydrolyzable amide, affinity reagent, or prodrug thereof.
    Type: Grant
    Filed: August 25, 1999
    Date of Patent: February 20, 2001
    Assignee: Glaxo Wellcome Inc.
    Inventors: Robert Carl Andrews, Marc Werner Andersen, Dulce Garrido Bubacz, Joseph Howing Chan, David John Cowan, Michael David Gaul, Daryl Lynn McDougald, David Lee Musso, Michael Howard Rabinowitz, Jennifer Badiang Stanford, Robert William Wiethe
  • Therapeutic benzonitriles
    Patent number: 5723452
    Abstract: The present invention relates to novel compounds of formula (I): ##STR1## or a physiologically functional derivative thereof, pharmaceutical formulations containing them, processes for their preparation and their use in therapy for the prophylaxis or treatment of HIV infection or inflammation are disclosed.
    Type: Grant
    Filed: August 21, 1996
    Date of Patent: March 3, 1998
    Assignee: Glaxo Wellcome Inc.
    Inventor: Joseph Howing Chan